Molecular Basis for Chemoselectivity Control in Oxidations of Internal Aryl‐Alkenes Catalyzed by Laboratory Evolved P450s
ChemBioChem · 2024
DOI: 10.1002/cbic.202400066 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Jordi Soler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Química Computacional i Catàlisi (IQCC) and Departament de Química, Universitat de Girona, Carrer Maria Aurèlia Capmany 69, 17003, Girona…. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme System, Alkenes, Oxidation-Reduction, Biocatalysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Generalitat de Catalunya AGAUR Beatriu de Pinós, 2021-SGR-00623, Spanish MICINN (Ministerio de Ciencia e Innovación).
Abstract (Originalsprache)
P450 enzymes naturally perform selective hydroxylations and epoxidations of unfunctionalized hydrocarbon substrates, among other reactions. The adaptation of P450 enzymes to a particular oxidative reaction involving alkenes is of great interest for the design of new synthetically useful biocatalysts. However, the mechanism that these enzymes utilize to precisely modulate the chemoselectivity and distinguishing between competing alkene double bond epoxidations and allylic C−H hydroxylations is sometimes not clear, which hampers the rational design of specific biocatalysts. In a previous work, a P450 from Labrenzia aggregata (P450 LA1 ) was engineered in the laboratory using directed evolution to catalyze the direct oxidation of trans ‐β‐methylstyrene to phenylacetone. The final variant, KS, was able to overcome the intrinsic preference for alkene epoxidation to directly generate a ketone product via the formation of a highly reactive carbocation intermediate. Here, additional library screening along this evolutionary lineage permitted to serendipitously detect a mutation that overcomes epoxidation and carbonyl formation by exhibiting a large selectivity of 94 % towards allylic C−H hydroxylation. A multiscalar computational methodology was applied to reveal the molecular basis towards this hydroxylation preference. Enzyme modelling suggests that introduction of a bulky substitution dramatically changes the accessible conformations of the substrate in the active site, thus modifying the enzymatic selectivity towards terminal hydroxylation and avoiding the competing epoxidation pathway, which is sterically hindered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Química Computacional i Catàlisi (IQCC) and Departament de Química, Universitat de Girona, Carrer Maria Aurèlia Capmany 69, 17003, Girona, Catalonia, Spain.
- Organic Chemistry and Biocatalysis, Faculty of Chemistry, Bielefeld University, Universitätsstraße 25, 33615, Bielefeld, Germany.
ORCID-Profile: Jordi Soler, Sebastian Gergel, Stephan C Hammer, Marc Garcia-Borràs
Förderung
- Generalitat de Catalunya AGAUR Beatriu de Pinós
- 2021-SGR-00623
- Spanish MICINN (Ministerio de Ciencia e Innovación)
- Ramón y Cajal
- Deutsche Forschungsgemeinschaft
- Spanish MIU (Ministerio de Universidades)
Zitieren
APA
Soler, J., Gergel, S., Hammer, S. C., & Garcia-Borràs, M. (2024). Molecular Basis for Chemoselectivity Control in Oxidations of Internal Aryl‐Alkenes Catalyzed by Laboratory Evolved P450s. ChemBioChem. https://doi.org/10.1002/cbic.202400066
Vancouver
Soler J, Gergel S, Hammer SC, Garcia-Borràs M. Molecular Basis for Chemoselectivity Control in Oxidations of Internal Aryl‐Alkenes Catalyzed by Laboratory Evolved P450s. ChemBioChem. 2024. doi:10.1002/cbic.202400066
BibTeX
@article{Soler2024,
author = {Soler, Jordi and Gergel, Sebastian and Hammer, Stephan C and Garcia-Borràs, Marc},
title = {Molecular Basis for Chemoselectivity Control in Oxidations of Internal Aryl‐Alkenes Catalyzed by Laboratory Evolved P450s},
journal = {ChemBioChem},
year = {2024},
doi = {10.1002/cbic.202400066}
}
EUVIMED